nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2B6—Thiotepa—sarcoma	0.187	0.38	CbGbCtD
Perphenazine—CYP1A2—Dacarbazine—sarcoma	0.0607	0.123	CbGbCtD
Perphenazine—CYP3A4—Thiotepa—sarcoma	0.0574	0.117	CbGbCtD
Perphenazine—CYP2C8—Etoposide—sarcoma	0.0384	0.078	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—sarcoma	0.0345	0.0702	CbGbCtD
Perphenazine—CYP1A2—Etoposide—sarcoma	0.0297	0.0604	CbGbCtD
Perphenazine—CYP3A4—Mitoxantrone—sarcoma	0.0247	0.0501	CbGbCtD
Perphenazine—CYP3A4—Vincristine—sarcoma	0.017	0.0345	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—sarcoma	0.0167	0.0339	CbGbCtD
Perphenazine—CYP3A4—Etoposide—sarcoma	0.0156	0.0316	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—sarcoma	0.0106	0.0216	CbGbCtD
Perphenazine—HTR7—pulmonary artery—sarcoma	0.00686	0.0639	CbGeAlD
Perphenazine—HTR2A—pulmonary artery—sarcoma	0.00428	0.0399	CbGeAlD
Perphenazine—HTR2A—hindlimb—sarcoma	0.00259	0.0241	CbGeAlD
Perphenazine—CALM3—mammary gland—sarcoma	0.00227	0.0211	CbGeAlD
Perphenazine—HTR2A—appendage—sarcoma	0.00222	0.0207	CbGeAlD
Perphenazine—CALM2—endothelium—sarcoma	0.00221	0.0206	CbGeAlD
Perphenazine—CALM1—endothelium—sarcoma	0.0022	0.0205	CbGeAlD
Perphenazine—HTR7—endothelium—sarcoma	0.00215	0.02	CbGeAlD
Perphenazine—AOX1—myometrium—sarcoma	0.00179	0.0166	CbGeAlD
Perphenazine—CALM1—mammary gland—sarcoma	0.00177	0.0165	CbGeAlD
Perphenazine—AOX1—seminal vesicle—sarcoma	0.00161	0.015	CbGeAlD
Perphenazine—CALM3—myometrium—sarcoma	0.00161	0.015	CbGeAlD
Perphenazine—CYP2C8—mammary gland—sarcoma	0.00148	0.0137	CbGeAlD
Perphenazine—CALM3—seminal vesicle—sarcoma	0.00145	0.0135	CbGeAlD
Perphenazine—HTR2A—endothelium—sarcoma	0.00134	0.0125	CbGeAlD
Perphenazine—CYP2C9—mammary gland—sarcoma	0.00131	0.0122	CbGeAlD
Perphenazine—CALM2—myometrium—sarcoma	0.00126	0.0118	CbGeAlD
Perphenazine—CALM1—myometrium—sarcoma	0.00126	0.0117	CbGeAlD
Perphenazine—CYP2C18—liver—sarcoma	0.00126	0.0117	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—sarcoma	0.00122	0.0113	CbGeAlD
Perphenazine—CALM2—embryo—sarcoma	0.00122	0.0113	CbGeAlD
Perphenazine—CALM1—embryo—sarcoma	0.00121	0.0113	CbGeAlD
Perphenazine—AOX1—cardiac atrium—sarcoma	0.00116	0.0109	CbGeAlD
Perphenazine—AOX1—uterus—sarcoma	0.00116	0.0108	CbGeAlD
Perphenazine—CALM2—seminal vesicle—sarcoma	0.00114	0.0106	CbGeAlD
Perphenazine—HTR1A—hematopoietic system—sarcoma	0.0011	0.0103	CbGeAlD
Perphenazine—CALM2—hematopoietic system—sarcoma	0.00109	0.0101	CbGeAlD
Perphenazine—CALM1—hematopoietic system—sarcoma	0.00108	0.0101	CbGeAlD
Perphenazine—Dysphagia—Dactinomycin—sarcoma	0.00106	0.00664	CcSEcCtD
Perphenazine—HTR7—hematopoietic system—sarcoma	0.00106	0.00983	CbGeAlD
Perphenazine—CALM3—cardiac atrium—sarcoma	0.00105	0.00977	CbGeAlD
Perphenazine—Cardiac arrest—Vincristine—sarcoma	0.00105	0.00653	CcSEcCtD
Perphenazine—Urinary retention—Vincristine—sarcoma	0.00105	0.00653	CcSEcCtD
Perphenazine—CALM2—connective tissue—sarcoma	0.00104	0.00973	CbGeAlD
Perphenazine—CALM3—uterus—sarcoma	0.00104	0.00972	CbGeAlD
Perphenazine—CALM1—connective tissue—sarcoma	0.00104	0.00969	CbGeAlD
Perphenazine—Ataxia—Vincristine—sarcoma	0.00103	0.00646	CcSEcCtD
Perphenazine—CYP2C19—hematopoietic system—sarcoma	0.00103	0.0096	CbGeAlD
Perphenazine—Pancytopenia—Thiotepa—sarcoma	0.00102	0.00635	CcSEcCtD
Perphenazine—HTR7—connective tissue—sarcoma	0.00102	0.00946	CbGeAlD
Perphenazine—AOX1—tendon—sarcoma	0.00102	0.00946	CbGeAlD
Perphenazine—Pancytopenia—Dactinomycin—sarcoma	0.00101	0.00631	CcSEcCtD
Perphenazine—Muscular weakness—Vincristine—sarcoma	0.00097	0.00605	CcSEcCtD
Perphenazine—Hyperglycaemia—Thiotepa—sarcoma	0.000967	0.00604	CcSEcCtD
Perphenazine—CALM2—smooth muscle tissue—sarcoma	0.000956	0.0089	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—sarcoma	0.000951	0.00886	CbGeAlD
Perphenazine—CALM2—skin of body—sarcoma	0.000943	0.00879	CbGeAlD
Perphenazine—CALM1—skin of body—sarcoma	0.000939	0.00875	CbGeAlD
Perphenazine—Jaundice—Thiotepa—sarcoma	0.000931	0.00582	CcSEcCtD
Perphenazine—HTR7—smooth muscle tissue—sarcoma	0.000929	0.00866	CbGeAlD
Perphenazine—Anaphylactoid reaction—Etoposide—sarcoma	0.00092	0.00575	CcSEcCtD
Perphenazine—HRH1—myometrium—sarcoma	0.000918	0.00855	CbGeAlD
Perphenazine—CALM3—tendon—sarcoma	0.000914	0.00852	CbGeAlD
Perphenazine—Pancytopenia—Vincristine—sarcoma	0.000902	0.00563	CcSEcCtD
Perphenazine—ADRA2A—myometrium—sarcoma	0.000901	0.0084	CbGeAlD
Perphenazine—CYP2C8—hematopoietic system—sarcoma	0.000899	0.00838	CbGeAlD
Perphenazine—Agranulocytosis—Thiotepa—sarcoma	0.000892	0.00557	CcSEcCtD
Perphenazine—CALM3—bone marrow—sarcoma	0.000886	0.00825	CbGeAlD
Perphenazine—Agranulocytosis—Dactinomycin—sarcoma	0.000885	0.00553	CcSEcCtD
Perphenazine—Pancytopenia—Mitoxantrone—sarcoma	0.000879	0.00549	CcSEcCtD
Perphenazine—Photosensitivity reaction—Vincristine—sarcoma	0.000867	0.00542	CcSEcCtD
Perphenazine—Glycosuria—Epirubicin—sarcoma	0.000849	0.0053	CcSEcCtD
Perphenazine—Cardiac arrest—Etoposide—sarcoma	0.000847	0.00529	CcSEcCtD
Perphenazine—CYP1A2—hematopoietic system—sarcoma	0.000842	0.00784	CbGeAlD
Perphenazine—AOX1—testis—sarcoma	0.000841	0.00783	CbGeAlD
Perphenazine—Hyperglycaemia—Mitoxantrone—sarcoma	0.000835	0.00521	CcSEcCtD
Perphenazine—Drowsiness—Mitoxantrone—sarcoma	0.000825	0.00515	CcSEcCtD
Perphenazine—CALM2—cardiac atrium—sarcoma	0.000824	0.00768	CbGeAlD
Perphenazine—Blood disorder—Epirubicin—sarcoma	0.000823	0.00514	CcSEcCtD
Perphenazine—CALM1—cardiac atrium—sarcoma	0.00082	0.00764	CbGeAlD
Perphenazine—CALM2—uterus—sarcoma	0.00082	0.00764	CbGeAlD
Perphenazine—Liver injury—Epirubicin—sarcoma	0.000817	0.0051	CcSEcCtD
Perphenazine—CALM1—uterus—sarcoma	0.000816	0.0076	CbGeAlD
Perphenazine—ADRA2A—seminal vesicle—sarcoma	0.000814	0.00758	CbGeAlD
Perphenazine—CYP2B6—hematopoietic system—sarcoma	0.000807	0.00751	CbGeAlD
Perphenazine—Jaundice—Mitoxantrone—sarcoma	0.000804	0.00502	CcSEcCtD
Perphenazine—CYP2C9—hematopoietic system—sarcoma	0.000799	0.00744	CbGeAlD
Perphenazine—AOX1—liver—sarcoma	0.000795	0.0074	CbGeAlD
Perphenazine—HRH1—hematopoietic system—sarcoma	0.000788	0.00734	CbGeAlD
Perphenazine—Glycosuria—Doxorubicin—sarcoma	0.000786	0.0049	CcSEcCtD
Perphenazine—Jaundice cholestatic—Epirubicin—sarcoma	0.000783	0.00489	CcSEcCtD
Perphenazine—Amenorrhoea—Epirubicin—sarcoma	0.000783	0.00489	CcSEcCtD
Perphenazine—ADRA2A—hematopoietic system—sarcoma	0.000774	0.00721	CbGeAlD
Perphenazine—Agranulocytosis—Mitoxantrone—sarcoma	0.00077	0.00481	CcSEcCtD
Perphenazine—Dysphagia—Etoposide—sarcoma	0.00077	0.00481	CcSEcCtD
Perphenazine—CALM2—lymphoid tissue—sarcoma	0.000764	0.00712	CbGeAlD
Perphenazine—Blood disorder—Doxorubicin—sarcoma	0.000762	0.00476	CcSEcCtD
Perphenazine—CALM1—lymphoid tissue—sarcoma	0.00076	0.00708	CbGeAlD
Perphenazine—HRH1—connective tissue—sarcoma	0.000759	0.00707	CbGeAlD
Perphenazine—CALM3—testis—sarcoma	0.000757	0.00705	CbGeAlD
Perphenazine—Hypoaesthesia—Vincristine—sarcoma	0.000757	0.00473	CcSEcCtD
Perphenazine—Liver injury—Doxorubicin—sarcoma	0.000756	0.00472	CcSEcCtD
Perphenazine—Bradycardia—Mitoxantrone—sarcoma	0.000754	0.00471	CcSEcCtD
Perphenazine—Erythema—Thiotepa—sarcoma	0.000747	0.00466	CcSEcCtD
Perphenazine—ADRA2A—connective tissue—sarcoma	0.000745	0.00694	CbGeAlD
Perphenazine—Erythema—Dactinomycin—sarcoma	0.000741	0.00463	CcSEcCtD
Perphenazine—HTR2A—embryo—sarcoma	0.000737	0.00687	CbGeAlD
Perphenazine—Dyskinesia—Epirubicin—sarcoma	0.000732	0.00457	CcSEcCtD
Perphenazine—Pancytopenia—Etoposide—sarcoma	0.000731	0.00456	CcSEcCtD
Perphenazine—Dysarthria—Epirubicin—sarcoma	0.000727	0.00454	CcSEcCtD
Perphenazine—Jaundice cholestatic—Doxorubicin—sarcoma	0.000724	0.00452	CcSEcCtD
Perphenazine—Amenorrhoea—Doxorubicin—sarcoma	0.000724	0.00452	CcSEcCtD
Perphenazine—CALM2—tendon—sarcoma	0.000718	0.00669	CbGeAlD
Perphenazine—CALM3—liver—sarcoma	0.000716	0.00667	CbGeAlD
Perphenazine—CALM1—tendon—sarcoma	0.000715	0.00666	CbGeAlD
Perphenazine—Vision blurred—Thiotepa—sarcoma	0.000704	0.00439	CcSEcCtD
Perphenazine—CYP2B6—skin of body—sarcoma	0.000701	0.00653	CbGeAlD
Perphenazine—HTR7—tendon—sarcoma	0.000698	0.0065	CbGeAlD
Perphenazine—CALM2—bone marrow—sarcoma	0.000696	0.00648	CbGeAlD
Perphenazine—HRH1—smooth muscle tissue—sarcoma	0.000694	0.00646	CbGeAlD
Perphenazine—CALM1—bone marrow—sarcoma	0.000692	0.00645	CbGeAlD
Perphenazine—Hepatocellular injury—Epirubicin—sarcoma	0.000688	0.00429	CcSEcCtD
Perphenazine—Agitation—Thiotepa—sarcoma	0.000686	0.00428	CcSEcCtD
Perphenazine—Abnormal dreams—Epirubicin—sarcoma	0.00068	0.00424	CcSEcCtD
Perphenazine—Dermatitis contact—Epirubicin—sarcoma	0.00068	0.00424	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—sarcoma	0.000677	0.00423	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—sarcoma	0.000673	0.0042	CcSEcCtD
Perphenazine—Jaundice—Etoposide—sarcoma	0.000669	0.00418	CcSEcCtD
Perphenazine—Leukopenia—Thiotepa—sarcoma	0.000668	0.00417	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—sarcoma	0.000668	0.00417	CcSEcCtD
Perphenazine—Leukopenia—Dactinomycin—sarcoma	0.000663	0.00414	CcSEcCtD
Perphenazine—HTR2A—hematopoietic system—sarcoma	0.000658	0.00613	CbGeAlD
Perphenazine—Cough—Thiotepa—sarcoma	0.000652	0.00407	CcSEcCtD
Perphenazine—Convulsion—Thiotepa—sarcoma	0.000647	0.00404	CcSEcCtD
Perphenazine—Erythema—Mitoxantrone—sarcoma	0.000645	0.00403	CcSEcCtD
Perphenazine—Hypertension—Thiotepa—sarcoma	0.000645	0.00403	CcSEcCtD
Perphenazine—Agranulocytosis—Etoposide—sarcoma	0.000641	0.004	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—sarcoma	0.000636	0.00397	CcSEcCtD
Perphenazine—HTR2A—connective tissue—sarcoma	0.000634	0.0059	CbGeAlD
Perphenazine—Dermatitis contact—Doxorubicin—sarcoma	0.000629	0.00393	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—sarcoma	0.000629	0.00393	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—sarcoma	0.000618	0.00386	CcSEcCtD
Perphenazine—Confusional state—Thiotepa—sarcoma	0.000614	0.00384	CcSEcCtD
Perphenazine—Hypoaesthesia—Etoposide—sarcoma	0.000613	0.00383	CcSEcCtD
Perphenazine—AOX1—lymph node—sarcoma	0.000609	0.00568	CbGeAlD
Perphenazine—CYP3A4—hematopoietic system—sarcoma	0.000609	0.00567	CbGeAlD
Perphenazine—Agitation—Vincristine—sarcoma	0.000608	0.0038	CcSEcCtD
Perphenazine—Vision blurred—Mitoxantrone—sarcoma	0.000608	0.00379	CcSEcCtD
Perphenazine—Infection—Thiotepa—sarcoma	0.000605	0.00378	CcSEcCtD
Perphenazine—Infection—Dactinomycin—sarcoma	0.000601	0.00375	CcSEcCtD
Perphenazine—CYP2D6—hematopoietic system—sarcoma	0.000599	0.00558	CbGeAlD
Perphenazine—Tachycardia—Thiotepa—sarcoma	0.000595	0.00371	CcSEcCtD
Perphenazine—CALM2—testis—sarcoma	0.000595	0.00554	CbGeAlD
Perphenazine—Leukopenia—Vincristine—sarcoma	0.000593	0.0037	CcSEcCtD
Perphenazine—CALM1—testis—sarcoma	0.000592	0.00551	CbGeAlD
Perphenazine—ADRA2A—cardiac atrium—sarcoma	0.000588	0.00547	CbGeAlD
Perphenazine—ADRA2A—uterus—sarcoma	0.000585	0.00545	CbGeAlD
Perphenazine—Anorexia—Thiotepa—sarcoma	0.000581	0.00363	CcSEcCtD
Perphenazine—HTR2A—smooth muscle tissue—sarcoma	0.00058	0.0054	CbGeAlD
Perphenazine—HTR7—testis—sarcoma	0.000578	0.00539	CbGeAlD
Perphenazine—Leukopenia—Mitoxantrone—sarcoma	0.000577	0.0036	CcSEcCtD
Perphenazine—Anorexia—Dactinomycin—sarcoma	0.000577	0.0036	CcSEcCtD
Perphenazine—Convulsion—Vincristine—sarcoma	0.000574	0.00358	CcSEcCtD
Perphenazine—Hypertension—Vincristine—sarcoma	0.000572	0.00357	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—sarcoma	0.000569	0.00355	CcSEcCtD
Perphenazine—CYP2B6—lymphoid tissue—sarcoma	0.000568	0.00529	CbGeAlD
Perphenazine—Cough—Mitoxantrone—sarcoma	0.000563	0.00351	CcSEcCtD
Perphenazine—CALM2—liver—sarcoma	0.000562	0.00524	CbGeAlD
Perphenazine—CALM1—liver—sarcoma	0.00056	0.00521	CbGeAlD
Perphenazine—Convulsion—Mitoxantrone—sarcoma	0.000559	0.00349	CcSEcCtD
Perphenazine—Hypertension—Mitoxantrone—sarcoma	0.000557	0.00348	CcSEcCtD
Perphenazine—Eczema—Epirubicin—sarcoma	0.000556	0.00347	CcSEcCtD
Perphenazine—CALM3—lymph node—sarcoma	0.000549	0.00511	CbGeAlD
Perphenazine—DRD2—testis—sarcoma	0.000547	0.00509	CbGeAlD
Perphenazine—HTR7—liver—sarcoma	0.000547	0.00509	CbGeAlD
Perphenazine—Somnolence—Thiotepa—sarcoma	0.000542	0.00338	CcSEcCtD
Perphenazine—Anaphylactic shock—Vincristine—sarcoma	0.00054	0.00337	CcSEcCtD
Perphenazine—Infection—Vincristine—sarcoma	0.000537	0.00335	CcSEcCtD
Perphenazine—CYP2C19—liver—sarcoma	0.000534	0.00497	CbGeAlD
Perphenazine—Confusional state—Mitoxantrone—sarcoma	0.000531	0.00331	CcSEcCtD
Perphenazine—Decreased appetite—Thiotepa—sarcoma	0.00053	0.00331	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—sarcoma	0.000529	0.0033	CcSEcCtD
Perphenazine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000526	0.00329	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—sarcoma	0.000526	0.00328	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—sarcoma	0.000526	0.00328	CcSEcCtD
Perphenazine—Infection—Mitoxantrone—sarcoma	0.000523	0.00326	CcSEcCtD
Perphenazine—HRH1—tendon—sarcoma	0.000521	0.00486	CbGeAlD
Perphenazine—Constipation—Thiotepa—sarcoma	0.000521	0.00325	CcSEcCtD
Perphenazine—Pain—Thiotepa—sarcoma	0.000521	0.00325	CcSEcCtD
Perphenazine—Shock—Mitoxantrone—sarcoma	0.000518	0.00323	CcSEcCtD
Perphenazine—Pain—Dactinomycin—sarcoma	0.000517	0.00323	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—sarcoma	0.000516	0.00322	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—sarcoma	0.000516	0.00322	CcSEcCtD
Perphenazine—Anorexia—Vincristine—sarcoma	0.000515	0.00322	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—sarcoma	0.000514	0.00321	CcSEcCtD
Perphenazine—Tachycardia—Mitoxantrone—sarcoma	0.000514	0.00321	CcSEcCtD
Perphenazine—ADRA2A—tendon—sarcoma	0.000512	0.00477	CbGeAlD
Perphenazine—Hypoglycaemia—Epirubicin—sarcoma	0.000512	0.00319	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—sarcoma	0.000509	0.00318	CcSEcCtD
Perphenazine—Hypotension—Vincristine—sarcoma	0.000505	0.00315	CcSEcCtD
Perphenazine—Anorexia—Mitoxantrone—sarcoma	0.000502	0.00313	CcSEcCtD
Perphenazine—CYP2C8—testis—sarcoma	0.000493	0.00459	CbGeAlD
Perphenazine—Hypotension—Mitoxantrone—sarcoma	0.000492	0.00307	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00049	0.00306	CcSEcCtD
Perphenazine—Insomnia—Vincristine—sarcoma	0.000489	0.00305	CcSEcCtD
Perphenazine—Urticaria—Thiotepa—sarcoma	0.000484	0.00302	CcSEcCtD
Perphenazine—Body temperature increased—Thiotepa—sarcoma	0.000482	0.00301	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—sarcoma	0.00048	0.003	CcSEcCtD
Perphenazine—Body temperature increased—Dactinomycin—sarcoma	0.000478	0.00299	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000477	0.00298	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—sarcoma	0.000475	0.00296	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—sarcoma	0.000473	0.00296	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—sarcoma	0.000471	0.00294	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—sarcoma	0.000471	0.00294	CcSEcCtD
Perphenazine—Decreased appetite—Vincristine—sarcoma	0.00047	0.00293	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—sarcoma	0.000469	0.00293	CcSEcCtD
Perphenazine—Dyspnoea—Mitoxantrone—sarcoma	0.000469	0.00293	CcSEcCtD
Perphenazine—Cough—Etoposide—sarcoma	0.000468	0.00292	CcSEcCtD
Perphenazine—Somnolence—Mitoxantrone—sarcoma	0.000468	0.00292	CcSEcCtD
Perphenazine—CYP2C8—liver—sarcoma	0.000466	0.00434	CbGeAlD
Perphenazine—Convulsion—Etoposide—sarcoma	0.000465	0.0029	CcSEcCtD
Perphenazine—Hypertension—Etoposide—sarcoma	0.000463	0.00289	CcSEcCtD
Perphenazine—Pain—Vincristine—sarcoma	0.000462	0.00289	CcSEcCtD
Perphenazine—Constipation—Vincristine—sarcoma	0.000462	0.00289	CcSEcCtD
Perphenazine—Decreased appetite—Mitoxantrone—sarcoma	0.000457	0.00286	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—sarcoma	0.000456	0.00285	CcSEcCtD
Perphenazine—Pain—Mitoxantrone—sarcoma	0.00045	0.00281	CcSEcCtD
Perphenazine—Constipation—Mitoxantrone—sarcoma	0.00045	0.00281	CcSEcCtD
Perphenazine—Hypersensitivity—Thiotepa—sarcoma	0.000449	0.0028	CcSEcCtD
Perphenazine—Hypersensitivity—Dactinomycin—sarcoma	0.000446	0.00278	CcSEcCtD
Perphenazine—CYP2B6—testis—sarcoma	0.000442	0.00412	CbGeAlD
Perphenazine—Confusional state—Etoposide—sarcoma	0.000441	0.00276	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—sarcoma	0.00044	0.00275	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—sarcoma	0.000439	0.00274	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—sarcoma	0.000438	0.00273	CcSEcCtD
Perphenazine—CYP1A2—liver—sarcoma	0.000436	0.00406	CbGeAlD
Perphenazine—HTR2A—tendon—sarcoma	0.000435	0.00406	CbGeAlD
Perphenazine—Infection—Etoposide—sarcoma	0.000435	0.00272	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—sarcoma	0.000434	0.00271	CcSEcCtD
Perphenazine—HRH1—testis—sarcoma	0.000432	0.00402	CbGeAlD
Perphenazine—Dysphagia—Epirubicin—sarcoma	0.000432	0.00269	CcSEcCtD
Perphenazine—Asthma—Epirubicin—sarcoma	0.000432	0.00269	CcSEcCtD
Perphenazine—Pruritus—Thiotepa—sarcoma	0.000431	0.00269	CcSEcCtD
Perphenazine—CALM2—lymph node—sarcoma	0.000431	0.00402	CbGeAlD
Perphenazine—CALM1—lymph node—sarcoma	0.000429	0.004	CbGeAlD
Perphenazine—Tachycardia—Etoposide—sarcoma	0.000427	0.00267	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—sarcoma	0.000427	0.00267	CcSEcCtD
Perphenazine—Body temperature increased—Vincristine—sarcoma	0.000427	0.00267	CcSEcCtD
Perphenazine—ADRA2A—testis—sarcoma	0.000424	0.00395	CbGeAlD
Perphenazine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000422	0.00263	CcSEcCtD
Perphenazine—Urticaria—Mitoxantrone—sarcoma	0.000418	0.00261	CcSEcCtD
Perphenazine—CYP2B6—liver—sarcoma	0.000418	0.00389	CbGeAlD
Perphenazine—Anorexia—Etoposide—sarcoma	0.000417	0.00261	CcSEcCtD
Perphenazine—Diarrhoea—Thiotepa—sarcoma	0.000417	0.0026	CcSEcCtD
Perphenazine—Body temperature increased—Mitoxantrone—sarcoma	0.000416	0.0026	CcSEcCtD
Perphenazine—CYP2C9—liver—sarcoma	0.000414	0.00386	CbGeAlD
Perphenazine—Diarrhoea—Dactinomycin—sarcoma	0.000414	0.00258	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—sarcoma	0.00041	0.00256	CcSEcCtD
Perphenazine—Hypotension—Etoposide—sarcoma	0.000409	0.00255	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—sarcoma	0.000407	0.00254	CcSEcCtD
Perphenazine—Dizziness—Thiotepa—sarcoma	0.000403	0.00252	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—sarcoma	0.000399	0.00249	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—sarcoma	0.000399	0.00249	CcSEcCtD
Perphenazine—Hypersensitivity—Vincristine—sarcoma	0.000398	0.00249	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—sarcoma	0.000395	0.00247	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—sarcoma	0.000394	0.00246	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—sarcoma	0.00039	0.00244	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—sarcoma	0.000389	0.00243	CcSEcCtD
Perphenazine—Somnolence—Etoposide—sarcoma	0.000389	0.00243	CcSEcCtD
Perphenazine—Hypersensitivity—Mitoxantrone—sarcoma	0.000388	0.00242	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—sarcoma	0.000385	0.0024	CcSEcCtD
Perphenazine—Headache—Thiotepa—sarcoma	0.000382	0.00238	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—sarcoma	0.000381	0.00238	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—sarcoma	0.000379	0.00237	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—sarcoma	0.000375	0.00234	CcSEcCtD
Perphenazine—Pain—Etoposide—sarcoma	0.000374	0.00234	CcSEcCtD
Perphenazine—Constipation—Etoposide—sarcoma	0.000374	0.00234	CcSEcCtD
Perphenazine—Diarrhoea—Vincristine—sarcoma	0.00037	0.00231	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000364	0.00228	CcSEcCtD
Perphenazine—HTR2A—testis—sarcoma	0.000361	0.00336	CbGeAlD
Perphenazine—Hyperglycaemia—Doxorubicin—sarcoma	0.00036	0.00225	CcSEcCtD
Perphenazine—Diarrhoea—Mitoxantrone—sarcoma	0.00036	0.00225	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—sarcoma	0.000359	0.00224	CcSEcCtD
Perphenazine—Dizziness—Vincristine—sarcoma	0.000357	0.00223	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—sarcoma	0.000356	0.00222	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—sarcoma	0.000352	0.0022	CcSEcCtD
Perphenazine—Urticaria—Etoposide—sarcoma	0.000348	0.00217	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—sarcoma	0.000347	0.00217	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—sarcoma	0.000346	0.00216	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—sarcoma	0.000344	0.00215	CcSEcCtD
Perphenazine—HTR2A—liver—sarcoma	0.000341	0.00318	CbGeAlD
Perphenazine—Oedema peripheral—Epirubicin—sarcoma	0.00034	0.00212	CcSEcCtD
Perphenazine—Headache—Vincristine—sarcoma	0.000339	0.00211	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—sarcoma	0.000332	0.00207	CcSEcCtD
Perphenazine—Headache—Mitoxantrone—sarcoma	0.00033	0.00206	CcSEcCtD
Perphenazine—CYP2D6—testis—sarcoma	0.000328	0.00306	CbGeAlD
Perphenazine—Bradycardia—Doxorubicin—sarcoma	0.000325	0.00203	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—sarcoma	0.000323	0.00201	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—sarcoma	0.000318	0.00199	CcSEcCtD
Perphenazine—CYP3A4—liver—sarcoma	0.000316	0.00294	CbGeAlD
Perphenazine—Oedema peripheral—Doxorubicin—sarcoma	0.000315	0.00197	CcSEcCtD
Perphenazine—HRH1—lymph node—sarcoma	0.000313	0.00292	CbGeAlD
Perphenazine—CYP2D6—liver—sarcoma	0.000311	0.00289	CbGeAlD
Perphenazine—Pruritus—Etoposide—sarcoma	0.00031	0.00193	CcSEcCtD
Perphenazine—ADRA2A—lymph node—sarcoma	0.000307	0.00286	CbGeAlD
Perphenazine—Erythema—Epirubicin—sarcoma	0.000301	0.00188	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—sarcoma	0.0003	0.00187	CcSEcCtD
Perphenazine—Dizziness—Etoposide—sarcoma	0.000289	0.00181	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—sarcoma	0.000289	0.0018	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—sarcoma	0.000283	0.00177	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—sarcoma	0.000278	0.00174	CcSEcCtD
Perphenazine—Agitation—Epirubicin—sarcoma	0.000276	0.00173	CcSEcCtD
Perphenazine—Headache—Etoposide—sarcoma	0.000274	0.00171	CcSEcCtD
Perphenazine—Syncope—Epirubicin—sarcoma	0.00027	0.00168	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—sarcoma	0.000269	0.00168	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—sarcoma	0.000267	0.00167	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—sarcoma	0.000264	0.00165	CcSEcCtD
Perphenazine—Cough—Epirubicin—sarcoma	0.000262	0.00164	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—sarcoma	0.000262	0.00164	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—sarcoma	0.000261	0.00163	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—sarcoma	0.00026	0.00162	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—sarcoma	0.000256	0.0016	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—sarcoma	0.00025	0.00156	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—sarcoma	0.000249	0.00156	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—sarcoma	0.000249	0.00155	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—sarcoma	0.000247	0.00154	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—sarcoma	0.000245	0.00153	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—sarcoma	0.000245	0.00153	CcSEcCtD
Perphenazine—Infection—Epirubicin—sarcoma	0.000244	0.00152	CcSEcCtD
Perphenazine—Cough—Doxorubicin—sarcoma	0.000243	0.00152	CcSEcCtD
Perphenazine—Shock—Epirubicin—sarcoma	0.000241	0.00151	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—sarcoma	0.000241	0.0015	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—sarcoma	0.00024	0.0015	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—sarcoma	0.000239	0.0015	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—sarcoma	0.000234	0.00146	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—sarcoma	0.000232	0.00145	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—sarcoma	0.000229	0.00143	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—sarcoma	0.000229	0.00143	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—sarcoma	0.000227	0.00142	CcSEcCtD
Perphenazine—Infection—Doxorubicin—sarcoma	0.000226	0.00141	CcSEcCtD
Perphenazine—Shock—Doxorubicin—sarcoma	0.000223	0.00139	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—sarcoma	0.000222	0.00139	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—sarcoma	0.000222	0.00138	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—sarcoma	0.000219	0.00137	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—sarcoma	0.000218	0.00136	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—sarcoma	0.000216	0.00135	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—sarcoma	0.000213	0.00133	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—sarcoma	0.000212	0.00132	CcSEcCtD
Perphenazine—Constipation—Epirubicin—sarcoma	0.00021	0.00131	CcSEcCtD
Perphenazine—Pain—Epirubicin—sarcoma	0.00021	0.00131	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—sarcoma	0.000205	0.00128	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—sarcoma	0.000202	0.00126	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—sarcoma	0.000202	0.00126	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—sarcoma	0.000197	0.00123	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—sarcoma	0.000195	0.00122	CcSEcCtD
Perphenazine—Pain—Doxorubicin—sarcoma	0.000194	0.00121	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—sarcoma	0.000194	0.00121	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—sarcoma	0.000194	0.00121	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—sarcoma	0.000181	0.00113	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—sarcoma	0.00018	0.00113	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—sarcoma	0.000179	0.00112	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—sarcoma	0.000174	0.00108	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—sarcoma	0.000168	0.00105	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—sarcoma	0.000167	0.00104	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—sarcoma	0.000162	0.00101	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—sarcoma	0.000161	0.001	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—sarcoma	0.000155	0.00097	CcSEcCtD
Perphenazine—Headache—Epirubicin—sarcoma	0.000154	0.00096	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—sarcoma	0.00015	0.000937	CcSEcCtD
Perphenazine—Headache—Doxorubicin—sarcoma	0.000142	0.000888	CcSEcCtD
Perphenazine—HTR1A—Signaling by GPCR—KRAS—sarcoma	1.76e-05	7.32e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—KRAS—sarcoma	1.75e-05	7.29e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL2—sarcoma	1.75e-05	7.27e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KDR—sarcoma	1.75e-05	7.26e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—HRAS—sarcoma	1.74e-05	7.24e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MDM2—sarcoma	1.73e-05	7.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MDM2—sarcoma	1.73e-05	7.19e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CREB1—sarcoma	1.71e-05	7.11e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—SRC—sarcoma	1.7e-05	7.06e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—SRC—sarcoma	1.7e-05	7.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL2—sarcoma	1.69e-05	7.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL2—sarcoma	1.69e-05	7.03e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HRAS—sarcoma	1.68e-05	7e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CREB1—sarcoma	1.68e-05	7e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CREB1—sarcoma	1.68e-05	6.98e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL2—sarcoma	1.67e-05	6.96e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—VEGFA—sarcoma	1.65e-05	6.88e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—VEGFA—sarcoma	1.65e-05	6.87e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MDM2—sarcoma	1.65e-05	6.86e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—EGFR—sarcoma	1.64e-05	6.81e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—NRAS—sarcoma	1.63e-05	6.79e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CCND1—sarcoma	1.63e-05	6.79e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—NRAS—sarcoma	1.63e-05	6.78e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HRAS—sarcoma	1.63e-05	6.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HRAS—sarcoma	1.63e-05	6.77e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—JUN—sarcoma	1.63e-05	6.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HRAS—sarcoma	1.62e-05	6.73e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CTNNB1—sarcoma	1.62e-05	6.72e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MDM2—sarcoma	1.61e-05	6.7e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—EGFR—sarcoma	1.61e-05	6.7e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KIT—sarcoma	1.61e-05	6.69e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—NRAS—sarcoma	1.61e-05	6.69e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—EGFR—sarcoma	1.61e-05	6.68e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MDM2—sarcoma	1.6e-05	6.67e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL2—sarcoma	1.6e-05	6.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MDM2—sarcoma	1.6e-05	6.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MDM2—sarcoma	1.6e-05	6.64e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KDR—sarcoma	1.59e-05	6.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HRAS—sarcoma	1.56e-05	6.51e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HRAS—sarcoma	1.56e-05	6.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—JUN—sarcoma	1.55e-05	6.46e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—KRAS—sarcoma	1.55e-05	6.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL2—sarcoma	1.54e-05	6.43e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL2—sarcoma	1.54e-05	6.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CTNNB1—sarcoma	1.54e-05	6.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KDR—sarcoma	1.54e-05	6.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KDR—sarcoma	1.54e-05	6.41e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CREB1—sarcoma	1.53e-05	6.37e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—KRAS—sarcoma	1.52e-05	6.33e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MYC—sarcoma	1.52e-05	6.33e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MYC—sarcoma	1.52e-05	6.32e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—KRAS—sarcoma	1.52e-05	6.31e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PLCG1—sarcoma	1.52e-05	6.3e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—JUN—sarcoma	1.5e-05	6.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—JUN—sarcoma	1.5e-05	6.25e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—HRAS—sarcoma	1.5e-05	6.23e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CTNNB1—sarcoma	1.49e-05	6.2e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CTNNB1—sarcoma	1.49e-05	6.2e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—HRAS—sarcoma	1.49e-05	6.19e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—EGFR—sarcoma	1.49e-05	6.19e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EGFR—sarcoma	1.49e-05	6.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KIT—sarcoma	1.47e-05	6.1e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—NRAS—sarcoma	1.47e-05	6.1e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—EGFR—sarcoma	1.47e-05	6.09e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—SRC—sarcoma	1.46e-05	6.08e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL2—sarcoma	1.44e-05	5.99e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL2—sarcoma	1.43e-05	5.96e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—CTNNB1—sarcoma	1.42e-05	5.92e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—VEGFA—sarcoma	1.42e-05	5.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KIT—sarcoma	1.42e-05	5.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KIT—sarcoma	1.42e-05	5.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—NRAS—sarcoma	1.42e-05	5.9e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—NRAS—sarcoma	1.42e-05	5.9e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MDM2—sarcoma	1.41e-05	5.88e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NRAS—sarcoma	1.41e-05	5.85e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KRAS—sarcoma	1.41e-05	5.84e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KRAS—sarcoma	1.4e-05	5.84e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCND1—sarcoma	1.4e-05	5.84e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—JUN—sarcoma	1.4e-05	5.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CREB1—sarcoma	1.4e-05	5.81e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCND1—sarcoma	1.4e-05	5.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—SRC—sarcoma	1.39e-05	5.8e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—JUN—sarcoma	1.39e-05	5.8e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MDM2—sarcoma	1.39e-05	5.79e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CTNNB1—sarcoma	1.39e-05	5.78e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MDM2—sarcoma	1.39e-05	5.78e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—KRAS—sarcoma	1.38e-05	5.76e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CTNNB1—sarcoma	1.38e-05	5.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—CTNNB1—sarcoma	1.38e-05	5.73e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—CTNNB1—sarcoma	1.38e-05	5.73e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CREB1—sarcoma	1.35e-05	5.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CREB1—sarcoma	1.35e-05	5.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—SRC—sarcoma	1.35e-05	5.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—SRC—sarcoma	1.35e-05	5.61e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—NRAS—sarcoma	1.34e-05	5.58e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EGFR—sarcoma	1.34e-05	5.56e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—HRAS—sarcoma	1.31e-05	5.47e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MYC—sarcoma	1.31e-05	5.45e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—NRAS—sarcoma	1.3e-05	5.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—NRAS—sarcoma	1.3e-05	5.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EGFR—sarcoma	1.29e-05	5.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EGFR—sarcoma	1.29e-05	5.38e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—HRAS—sarcoma	1.29e-05	5.38e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—HRAS—sarcoma	1.29e-05	5.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—SRC—sarcoma	1.29e-05	5.35e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EGFR—sarcoma	1.28e-05	5.33e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MDM2—sarcoma	1.27e-05	5.27e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL2—sarcoma	1.26e-05	5.26e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—KRAS—sarcoma	1.26e-05	5.25e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—SRC—sarcoma	1.26e-05	5.23e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—SRC—sarcoma	1.25e-05	5.2e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—sarcoma	1.25e-05	5.19e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—sarcoma	1.25e-05	5.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—SRC—sarcoma	1.24e-05	5.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—SRC—sarcoma	1.24e-05	5.18e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL2—sarcoma	1.24e-05	5.17e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL2—sarcoma	1.24e-05	5.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NRAS—sarcoma	1.24e-05	5.15e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCND1—sarcoma	1.23e-05	5.13e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—JUN—sarcoma	1.23e-05	5.11e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—sarcoma	1.22e-05	5.09e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—KRAS—sarcoma	1.22e-05	5.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—KRAS—sarcoma	1.22e-05	5.08e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—sarcoma	1.22e-05	5.08e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CTNNB1—sarcoma	1.22e-05	5.08e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—sarcoma	1.22e-05	5.06e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCND1—sarcoma	1.21e-05	5.04e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—JUN—sarcoma	1.21e-05	5.03e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCND1—sarcoma	1.21e-05	5.03e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KRAS—sarcoma	1.21e-05	5.03e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NRAS—sarcoma	1.21e-05	5.03e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—JUN—sarcoma	1.21e-05	5.02e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NRAS—sarcoma	1.2e-05	5e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CTNNB1—sarcoma	1.2e-05	4.99e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CTNNB1—sarcoma	1.2e-05	4.98e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NRAS—sarcoma	1.2e-05	4.98e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NRAS—sarcoma	1.2e-05	4.98e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—sarcoma	1.19e-05	4.97e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—sarcoma	1.19e-05	4.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—sarcoma	1.18e-05	4.91e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—sarcoma	1.18e-05	4.91e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—sarcoma	1.18e-05	4.89e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MDM2—sarcoma	1.16e-05	4.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—sarcoma	1.15e-05	4.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—sarcoma	1.15e-05	4.8e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2—sarcoma	1.13e-05	4.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—sarcoma	1.13e-05	4.69e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—sarcoma	1.13e-05	4.68e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—sarcoma	1.12e-05	4.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MDM2—sarcoma	1.12e-05	4.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MDM2—sarcoma	1.12e-05	4.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—sarcoma	1.12e-05	4.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—sarcoma	1.12e-05	4.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—sarcoma	1.12e-05	4.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—sarcoma	1.12e-05	4.64e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—sarcoma	1.1e-05	4.59e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SRC—sarcoma	1.1e-05	4.59e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—sarcoma	1.1e-05	4.58e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JUN—sarcoma	1.1e-05	4.58e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—sarcoma	1.1e-05	4.56e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	1.09e-05	4.54e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—sarcoma	1.09e-05	4.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—sarcoma	1.09e-05	4.54e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—sarcoma	1.09e-05	4.51e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—sarcoma	1.08e-05	4.5e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—sarcoma	1.08e-05	4.47e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—sarcoma	1.07e-05	4.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—sarcoma	1.07e-05	4.46e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—sarcoma	1.07e-05	4.43e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—sarcoma	1.06e-05	4.41e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—sarcoma	1.06e-05	4.4e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—sarcoma	1.05e-05	4.39e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—sarcoma	1.04e-05	4.34e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—sarcoma	1.04e-05	4.33e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—sarcoma	1.04e-05	4.33e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—sarcoma	1.04e-05	4.32e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—sarcoma	1.04e-05	4.32e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—sarcoma	1.03e-05	4.3e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—sarcoma	1.03e-05	4.29e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—sarcoma	1.03e-05	4.29e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—sarcoma	1.03e-05	4.29e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—sarcoma	1.03e-05	4.28e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—sarcoma	1.01e-05	4.19e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JUN—sarcoma	1e-05	4.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—sarcoma	9.99e-06	4.15e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—sarcoma	9.99e-06	4.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—sarcoma	9.97e-06	4.15e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—sarcoma	9.88e-06	4.11e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—sarcoma	9.87e-06	4.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—sarcoma	9.81e-06	4.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—sarcoma	9.74e-06	4.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—sarcoma	9.74e-06	4.05e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—sarcoma	9.73e-06	4.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JUN—sarcoma	9.72e-06	4.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JUN—sarcoma	9.72e-06	4.04e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—sarcoma	9.71e-06	4.04e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—sarcoma	9.67e-06	4.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—sarcoma	9.64e-06	4.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—sarcoma	9.64e-06	4.01e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—sarcoma	9.62e-06	4e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—sarcoma	9.51e-06	3.96e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—sarcoma	9.5e-06	3.95e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—sarcoma	9.49e-06	3.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—sarcoma	9.49e-06	3.95e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—sarcoma	9.49e-06	3.95e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—sarcoma	9.25e-06	3.85e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—sarcoma	9.2e-06	3.83e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—sarcoma	9.13e-06	3.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—sarcoma	9.06e-06	3.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—sarcoma	9.01e-06	3.75e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—sarcoma	8.99e-06	3.74e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—sarcoma	8.97e-06	3.73e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—sarcoma	8.85e-06	3.68e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—sarcoma	8.84e-06	3.68e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—sarcoma	8.8e-06	3.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—sarcoma	8.78e-06	3.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—sarcoma	8.76e-06	3.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—sarcoma	8.76e-06	3.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—sarcoma	8.72e-06	3.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—sarcoma	8.72e-06	3.62e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—sarcoma	8.67e-06	3.6e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—sarcoma	8.66e-06	3.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—sarcoma	8.49e-06	3.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—sarcoma	8.49e-06	3.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—sarcoma	8.38e-06	3.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—sarcoma	8.38e-06	3.49e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—sarcoma	8.18e-06	3.4e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—sarcoma	8.12e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—sarcoma	8.07e-06	3.36e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—sarcoma	7.99e-06	3.32e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—sarcoma	7.97e-06	3.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—sarcoma	7.9e-06	3.28e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—sarcoma	7.81e-06	3.25e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—sarcoma	7.81e-06	3.25e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—sarcoma	7.76e-06	3.23e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—sarcoma	7.64e-06	3.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—sarcoma	7.64e-06	3.18e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—sarcoma	7.64e-06	3.18e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—sarcoma	7.62e-06	3.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—sarcoma	7.46e-06	3.1e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—sarcoma	7.27e-06	3.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—sarcoma	7.22e-06	3e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—sarcoma	7.22e-06	3e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—sarcoma	6.95e-06	2.89e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—sarcoma	6.63e-06	2.76e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—sarcoma	6.41e-06	2.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—sarcoma	6.41e-06	2.67e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—sarcoma	6.34e-06	2.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—sarcoma	6.13e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—sarcoma	6.13e-06	2.55e-05	CbGpPWpGaD
